Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Clinical trial NCT05566756 · COMPLETED
Trial details
- NCT number
- NCT05566756
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-28
- Primary completion
- 2025-05-28
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.